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Abstract
Introduction: Despite many advances in our understanding of the molecular basis of disc degeneration, there
remains a paucity of preclinical models which can be used to study the biochemical and molecular events that
drive disc degeneration, and the effects of potential therapeutic interventions. The goal of this study is to
characterize global gene expression changes in a disc organ culture system that mimics early nontraumatic disc
degeneration.
Methods: To mimic a degenerative insult, rat intervertebral discs were cultured in the presence of TNF-a, IL-1b
and serum-limiting conditions. Gene expression analysis was performed using a microarray to identify differential
gene expression between experimental and control groups. Differential pattern of gene expression was confirmed
using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) or Western blot.
Results: Treatment resulted in significant changes in expression of more than 1,000 genes affecting many aspects
of cell function including cellular movement, the cell cycle, cellular development, and cell death and proliferation.
Many of the most highly upregulated and downregulated genes have known functions in disc degeneration and
extracellular matrix hemostasis. Construction of gene networks based on known cellular pathways and expression
data from our analysis demonstrated that the network associated with cell death, cell cycle regulation and DNA
replication and repair was most heavily affected in this model of disc degeneration.
Conclusions: This rat organ culture model uses cytokine exposure to induce wide gene expression changes with
the most affected genes having known reported functions in disc degeneration. We propose that this model is a
valuable tool to study the etiology of disc degeneration and evaluate potential therapeutic treatments.
Introduction
Amongst the many potential pain generators in the lumbar
spine, symptomatic disc degeneration is thought to be a
significant contributor to low back pain (LBP) [1,2] and
accounts for more than 25% of lumbar fusion surgery per-
formed in the USA [3]. By some estimates, LBP results in
direct and indirect health-care expenditures exceeding
$100 billion per year, a considerable portion of which is
due to discogenic pain [4]. Despite the scale of this clinical
problem, many aspects of the pathogenesis associated with
LBP remain incompletely characterized. The highly vari-
able nature of associated symptoms and the presence of
multiple potential sources of pain within the spine often
confound efforts to accurately identify and study disc
degeneration in live subjects. However, most authorities
agree that there is a strong link between intervertebral disc
degeneration and the LBP [5,6].
Establishing clinically relevant models of disc degen-
eration has also proven difficult. In contrast to humans,
disc degeneration is not commonly seen in most quad-
rupedal animals, likely due to a variety of factors such
as mineral composition, vertebral range of motion,
extracellular matrix (ECM) composition, cell type, and
weight distribution [7]. Different strategies have been
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developed to induce disc degeneration in animals
including gene silencing, application of supraphysiologic
loading, and disc injury. One theoretical advantage of
using in vitro models to study disc degeneration is the
ability to carefully control confounding environmental
variables, which may differ between individual animals
such as nutrition and the loading environment. To date,
most widely used in vitro studies are performed with
cells isolated from the intervertebral disc, which are
then either grown in monolayer or suspended in a
matrix that allows cells to assume a three-dimensional
phenotype. To capture the benefits associated with in
vitro models of disc degeneration while maintaining
essentially normal cell density and distribution and the
native ECM, we have developed and performed initial
characterization of a disc organ culture model using
intact rat intervertebral discs [8]. Since the hallmark
catabolic processes such as matrix breakdown and
decreased cellular biosynthesis during human degenera-
tion are mediated by a number of cytokines, including
IL-1b and TNF-a [9-14], we chose to mimic the degen-
erative state by treating organ-cultured discs with a
cocktail containing both these cytokines.
Our initial investigations focused on targeted evalua-
tion of a few key molecules known to be intermediaries
in the degenerative cascade or essential components of
the disc ECM [8]. In the present study, we hope to
expand on our initial studies to demonstrate that this
model replicates the degenerative phenotype in humans
through analysis of global gene expression changes. Our
results clearly indicate that this model is a good alterna-
tive to in vivo and cell-based in vitro models of interver-
tebral disc degeneration.
Materials and methods
Disc harvesting and organ culture
The rat tissue samples were obtained under a protocol
approved by the Institutional Animal Care and Use
Committee (IACUC) of the Thomas Jefferson University
(Protocol number 703H). Rat lumbar disc specimens
were isolated using a method reported earlier by Pon-
nappan et al. [8]. Briefly, using a sterile surgical blade
(number 15) the whole lumbar intervertebral discs
(IVDs with the endplates were dissected (n = 6 discs/
animal) and maintained in organ culture in 12-well cell
culture plates. All experimental lumbar discs were cul-
tured in DMEM containing 1% FBS, 10 ng/ml IL-1b
(R&D Systems, Inc., Minneapolis, MN, USA), 100 ng/ml
TNF-a, 50 μg/ml L-ascorbate, 40 mM NaCl, antibiotics
and antimycotics (Cellgro, Mediatech, Inc., Herndon,
VA, USA). Control discs were cultured in DMEM con-
taining 10% FBS, 50 μg/ml L-ascorbate, 40 mM NaCl
and antibiotics without any cytokines. The discs were
maintained in culture for 10 days. The complete
medium was replaced every two days for both groups.
In each experiment, six lumbar discs from one animal
were used per group. The number of animals used for
each study is indicated where appropriate.
Microarray analysis
Total RNA was extracted using the RNeasy Micro kit
(Qiagen, Valencia, CA, USA, ) according to the manu-
facturer’s instructions. DNase-treated RNA was quanti-
fied on a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies, Inc., Wilmington, DE, USA),
followed by RNA quality assessment by analysis on an
Agilent 2100 bioanalyzer (Agilent, Palo Alto, CA, USA).
RNA amplification and labeling was performed from 50
ng total RNA by the WT-Ovation Pico RNA amplifica-
tion system (NuGen Technologies, Inc., San Carlos, CA,
USA) as described previously [15]. Each Affymetrix Rat
Gene array (RaGene 1.0 ST v1) (Affymetrix, Santa Clara,
CA, USA) was hybridized with fragmented and biotin-
labeled target for 18 h. Arrays were then washed and
stained using Gene-chip Fluidic Station 450, and hybri-
dization signals were amplified using antibody amplifica-
tion with goat IgG (Sigma-Aldrich, St Louis, MO, USA)
and anti-streptavidin biotinylated antibody (Vector
Laboratories, Burlingame, CA, USA). Chips were
scanned on an Affymetrix Gene Chip Scanner 3000,
using Command Console software. Background correc-
tion and normalization were done using Robust Multi-
chip Average (RMA) with Gene-spring V 11.5 software
(Agilent). A volcano plot was used to identify differen-
tially expressed genes using the unpaired two-sample
Student’s t test, assuming significance for P values ≤
0.05, and fold changes ≥1.5. A heat map was generated
by Gene-spring software V 11.5. The differentially
expressed gene list was loaded into Ingenuity Pathway
Analysis (IPA-8.8) software to perform biological net-
work and functional analyses following a previously
described method [16]. In short, IPA was used to con-
vert a list of differentially expressed genes into a set of
relevant networks based on a continually updated data-
base of known molecular pathways. This analysis is
intended to suggest which cellular processes are most
likely to be affected by the gene expression changes tak-
ing place in a given experiment. This process generates
a network score that reflects the probability that a simi-
lar group of genes equal to or greater than the number
in the network could be achieved through chance alone.
Previous similar analyses have used a score of more
than 10 as a cutoff for identifying relevant gene net-
works [16] with higher values corresponding to net-
works more likely to be affected by the expression
changes seen in the experiment. Four animals for the
control and four animals for the experimental group (24
discs/group) were used for this study, n = 4 independent
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experiments. The microarray data can be accessed at the
Gene Expression Omnibus number GSE42611 [17].
RNA extraction and quantitative real-time PCR
The discs were collected and the annulus fibrosus (AF)
was separated from the nucleus pulposus (NP) as in pre-
viously described method [8]. Total RNA was extracted
from NP tissue (RNeasy Micro kit, Qiagen) according to
the manufacturer’s instructions. The RNA samples were
treated with DNase I digestion prior to conversion into
cDNA. Single-stranded cDNA was synthesized from 0.5
μg of total RNA using RNA to cDNA EcoDry Premix
(Oligo dT) (Clontech Laboratories, Inc., Mountain View,
CA, USA) and quantitative (q) RT-PCR was performed
using SYBR Green PCR Master Mix (Applied Biosys-
tems, Foster City, CA, USA) on an ABI 7900 HT
sequence detection system. A melting curve analysis was
performed to ensure primer specificity. The amount of
PCR product was estimated using a relative standard
curve quantification method. Expression was normalized
by using housekeeping gene hypoxanthine phosphoribo-
syltransferase 1 (Hprt1). All the primers used were
synthesized by Integrated DNA Technologies, Inc. (Cor-
alville, IA, USA). Sequences for primers are presented in
Table 1.
Western blot
Expression of Syndecan 4 (SDC-4) and Keratin 19
(KRT19) were evaluated by Western blot analysis. NP
tissue was washed with cold PBS and was extracted with
lysis buffer (Cell Signaling Technologies, Beverly, MA,
USA) at 4°C for 24 h. The lysis buffer contains: 20 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2 EDTA, 1
mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate,
1 mM b-glycerophosphate, 1 mM Na3VO4, 1 μg/ml
leupeptin, 1 mM PMSF and 1× complete protease inhi-
bitors (Roche, Indianapolis, IN, USA). The tissue lysate
was centrifuged for 10 min at 14,000 × g to collect the
clear tissue extract. Protein concentration in the extract
was determined using a Pierce BCA protein assay kit
(Thermo Fisher Scientific Inc., Rockford, IL, USA).
Lysates were treated with 0.1 U/ml chondroitinase ABC
(Sigma-Aldrich) in 50 mM Tris-acetate EDTA buffer at
37°C for 1 h. Protein extracts (10 μg) were centrifuged
at 4°C for 2 min at 14,000 × g and resolved on NuPAGE
4 to 12% Bis-Tris Gels (Invitrogen, Carlsbad, CA, USA).
Proteins were transferred onto Immobilon-P Membrane
(Merck Millipore, Darmstadt, Germany). The membrane
was blocked with 5% nonfat dry milk in PBS with 0.1%
Tween-20 and incubated overnight at 4°C in 3% nonfat
dry milk in PBS with 0.1% Tween-20 with the appropri-
ate antibody anti-Syndecan 4 (Abcam, Cambridge, UK)
and anti-Keratin 19 (Cell Signaling Technologies),
respectively. The binding of the secondary antibody was
detected by enhanced chemiluminescence (ECL-Plus,
GE Healthcare, Little Chalfont, UK). Results were nor-
malized to the content of tubulin detected with mono-
clonal antibody beta-tubulin (1:3000, Developmental
Studies Hybridoma Bank (DSHB)), n = 3 independent
experiments.
Senescence-associated b-galactosidase staining
The primary rat NP cells were isolated using a method
reported earlier by Wang et al. [10]. Cells were plated in
Lab-Tek II Chamber Slide System (Nalge Nunc Interna-
tional, Rochester, NY, USA) and treated with 10 ng/ml
IL-1b and 10 ng/ml TNF-a for 10 days. The slides were
rinsed with PBS, fixed with fixative solution for 15 min
at room temperature, and incubated overnight at 37°C
with fresh SA-b-gal staining solution (Senescence Detec-
tion Kit, Abcam). Cells were observed under a light
microscope for development of blue color. The images
were captured using a Nikon Eclipse E600 (Nikon,
Tokyo, Japan).
Data analysis
Statistical analysis was performed using Sigma Plot 11.2
statistical software (Systat Software, Inc., Chicago, IL,
USA). Differences between groups in continuous vari-
ables were analyzed by the Student’s t test assuming sig-
nificance at P < 0.05.
Results
Microarray experiment
Following organ culture experiment (Figure 1A), RNA
was extracted and microarray analysis was performed.
Figure 1B depicts the heat map of the significant NP
gene expression profile changes between the control
(Ctr) and experimental (Exp) groups, demonstrating
Table 1 Primers used for real-time RT-PCR.

























F, forward primer; R, reverse primer.
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Figure 1 (A) Schematic showing disc organ culture setup. Culturing discs under low pO2, in hyperosmolar, nutritionally limiting media with
exposure to proinflammatory cytokines mimics the molecular changes characteristic of disc degeneration. (B) Microarray analysis of rat discs
treated with TNF-a and IL-1b for 10 days. The heat map displays gene expression patterns of 1,036 genes after treatment. The relative levels of
gene expression are depicted with a color scale, where blue represents the lowest and red represents the highest level of expression. (C)
Volcano plot of microarray data depicting the significant differences (P < 0.05) in expression patterns between the control (Ctr.) and
experimental (Exp.) groups, where the red plots represent a 1.5-fold or more difference in expression patterns between the two groups. (D) Pie
chart showing differentially expressed genes based on major molecular and cellular functions. The total numbers of genes associated with each
specific function are listed. Note that some genes may have multiple functions and can be classified in several categories (see Table 2), N = 4
independent experiments.
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more than 1,000 individual genes that were either upre-
gulated or downregulated by more than 1.5-fold in the
experimental model. In total, 1,036 genes demonstrated
a significant upregulation or downregulation based on
the microarray results. Figure 1C more clearly depicts
the relative balance between genes either upregulated or
downregulated by more than 1.5-fold (P < 0.05) in the
experimental model compared to the control group
using a volcano plot; significantly upregulated genes are
depicted by red dots to the right of the center while sig-
nificantly downregulated genes are denoted by red dots
to the left of the center. From a functional standpoint,
genes changing expression patterns in the experimental
model could be divided into several different known cel-
lular functions as seen in Figure 1D: 138 genes affect
cellular movement, 73 genes affect the cell cycle, 156
genes affect cellular development, 139 genes are
involved in cellular death and 180 genes are known
intermediaries in cellular growth and proliferation.
Genes contributing to these major cellular functions are
shown in Table 2.
The 10 genes most highly upregulated and downregu-
lated in the experimental group are depicted in
Figure 2A and 2B, respectively, and the related expres-
sion levels are reported in Table 3. Upregulated genes
with known roles in disc degeneration included interleu-
kin-6 (Il-6), matrix metallopeptidase 3 (Mmp3), and a
disintegrin and metalloproteinase with thrombospondin
motifs 5 (Adamts5). Highly downregulated genes with
known roles in maintenance of normal disc phenotype
or as markers for NP cells included Krt19, asporin
(Aspn), collagen I alpha-1 (Col1a1), collagen I alpha-2
(Col1a2) and insulin-like growth factor 1 (Igf1).
RNA extraction and quantitative real-time PCR
Validation of differentially expressed genes by real-time RT-
PCR
Confirmation of microarray data with qRT-PCR was
performed for selected genes from the top 10 upregu-
lated and downregulated genes as shown in Table 3.
Also included in these confirmatory experiments was
Sdc-4, as it was also significantly upregulated in the
array data and has recently been shown to be a key reg-
ulator of Adamts5 activity in the IVD [10]. Experimental
group demonstrated significant upregulation of chemo-
kine (C-C motif) ligand 20 (Ccl20), Il-6, Adamts5, and
Mmp3 by almost 216-fold (P < 0.001), 45-fold (P =
0.003), 26-fold (P = 0.02) and 42-fold (P = 0.048),
respectively, compared to control (Figure 2C and 2D).
Alternatively, Krt19 and Krt8 were significantly downre-
gulated in the experimental group by 27-fold (P < 0.001)
and 17-fold (P < 0.001), respectively, compared to con-
trols (Figure 2E). Col1a1 and Col1a2 were not evaluated
using qRT-PCR in this study as these genes have
previously been shown to be downregulated in experi-
mental discs using the same organ culture model [8].
Notably, the relative changes in gene expression
between experimental and control groups were larger
when analyzed by qRT-PCR suggesting that microarray
analysis may be a conservative evaluation of the gene
expression differences between the control and the
experimental discs.
Western blot analysis
Western blot analysis was performed to demonstrate the
effect of treatment on the expression of SDC-4 and
KRT19. Similar to the results for the microarray and the
qRT-PCR experiments, Western blot analysis showed a
robust downregulation of KRT19 protein in the experi-
mental group compared to the control group (Figure
2F). There was a strong increase in SDC4 levels in the
experimental discs when compared to the control discs
(Figure 2F).
Functional gene networks
Figures 3, 4, and 5 show the IPA-generated gene net-
works. The network depicted in Figure 3A is associated
with cell death, cell cycle, and DNA replication, recom-
bination and repair, and has a score of 31. The network
depicted in Figure 3B is associated with cellular growth
and proliferation, tissue development and cancer, and
has a score of 27. The network shown in Figure 4A is
associated with cellular development and vascular func-
tion and development, and has a score of 27. The net-
work illustrated in Figure 4B is associated with
carbohydrate metabolism and protein synthesis and has
a score of 16. Finally, the network in Figure 5 depicts
genes related to cellular movement, immune cell traf-
ficking, cell-to-cell signaling and cellular interactions
and has a score of 24.
Effect of cytokines on NP cell senescence
Staining for SA-b-gal was used to measure the effect of
proinflammatory cytokines on phenotype of primary rat
NP cells. Increased blue staining was evident in the
cytoplasm of the cells treated for 10 days compared to
the control group, indicating onset of senescent cell
phenotype (Figure S1 in Additional file 1).
Discussion
Modeling human disc degeneration with a reliable and
reproducible animal model is an important step toward
further characterization of disc degeneration given the
wide inter-individual variation in gene expression, which
limits studies on human tissue samples. Furthermore, as
our understanding of disc degeneration advances, a
reproducible animal model of disc degeneration will
enable controlled testing of therapeutic strategies. Many
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in vivo and ex vivo models have been proposed to study
disc degeneration but most rely on nonanatomic and
nonphysiologic methods of inducing degeneration. AF
puncture models continue to be a popular method of
inducing degenerative changes in quadrupeds to mimic
a degenerative phenotype. However, techniques that rely
on annular puncture and injection of an enzyme into
the disc space to induce degeneration may not accu-
rately model this process in humans [18-22]. Similarly,
the use of species that are prone to the development of
Table 2 Differentially expressed genes based on major molecular and cellular functions.
No. Molecular functions No. of molecules P value
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Figure 2 (A-B) Diagrams illustrating genes with the highest upregulation (A) and downregulation (B) in expression between the
experimental (Exp.) and control (Ctr.) discs. (C-E) Quantitative RT-PCR confirms the changes in gene expression identified by microarray
analysis between the Ctr. and Exp. discs. Quantitative PCR expression levels were normalized to hypoxanthine phosphoribosyltransferase 1 (Hprt1)
and shown relative to the Ctr., N = 3 independent experiments. (F) Western blot analysis of rat nucleus pulposus (NP) tissue lysates shows an
increase in expression of Syndecan-4 (SDC4) and a decrease in expression of Keratin 19 (KRT19) in the experimental group, N = 3 independent
experiments.
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disc degeneration, such as the sand rat, or other gene
knockout models that alter disc biology may not com-
pletely reflect the complexities in etiology of human
degenerative changes [23-27]. In contrast, an ideal
model would not require traumatic injury to the struc-
ture of the intervertebral disc and instead induce degen-
eration using processes native to the IVD. In this
investigation, we characterized a rat organ culture
model of disc degeneration through analysis of global
gene expression using microarray approach that was
further validated using quantitative mRNA and protein
expression analysis. This nontraumatic model of disc
degeneration, based on the use of inflammatory cyto-
kines IL-1b and TNF-a, mimics known gene expression
patterns observed in the degenerative human disc.
Moreover, this model allows for the evaluation of ana-
bolic, catabolic and inflammatory processes that become
imbalanced in disc degradation leading to degradation
of the ECM and ultimately to loss of the biomechanical
properties of the intervertebral disc.
The phenotypic and genotypic changes associated with
disc degeneration are complex, reflecting the interrelat-
edness of many distinct processes. We found changes in
the expression of genes involved in a number of cellular
functions; genes controlling cellular growth and prolif-
eration (181 genes) and cellular development (156
genes) were the most frequently affected. Similarly, IPA
network analysis demonstrated the highest gene network
score amongst genes involved in cell death, cell cycle,
and DNA replication, recombination and repair. This
finding, and the increased incidence of SA-b-gal in cyto-
kine-treated NP cells, suggests that during degeneration
disc cells may be particularly susceptible to processes
such as senescence [28], at the same time as identifying
genes that are likely to be related to these processes.
Furthermore, these IPA networks highlight the web of
interrelated pathways that are differentially regulated in
discs undergoing degenerative changes; not only may
changes in expression of a single gene have wide down-
stream consequences but these figures hint that the
existence of a single key mediator of disc degeneration
is unlikely.
Analysis of the top 20 most affected genes indicate
that many genes are known mediators of disc degenera-
tion or serve a role in maintaining normal disc function.
Prior characterization of gene expression patterns from
degenerative human IVD tissue has shown a similar
breadth of changes in global expression patterns [29-31].
These gene expression analyses suggest that many dif-
ferent processes are altered in disc degeneration,
although most current research tends to focus on the
patterns of inflammatory mediator expression. In agree-
ment with recent studies that showed enhanced chemo-
kine-mediated macrophage migration by inflammatory
cytokines [32], one of the highly upregulated molecules
identified in this study is Ccl20. This chemokine is a
major regulator of macrophage and mast cells migration
and has been reported to be upregulated in other
arthritic disorders [33,34]. Gruber et al. compared global
gene expression profiles between discs with different
Table 3 Top 10 molecules which demonstrated the highest upregulation and downregulation in treated discs.
Gene symbol Gene description Expression levels
ORM1/ORM2 Orosomucoid 1 31.714
CCL20 Chemokine (C-C motif) ligand 20 24.260
TFPI2 Tissue factor pathway inhibitor 2 23.074
IL6 Interleukin 6 21.493
MMP3 Matrix metallopeptidase 3 21.267
CYP7B1 Cytochrome P450, family 7, subfamily b, 20.756
ADAMTS5 ADAM metallopeptidase with thrombospondin type 1 motif, 5 19.843
LCN2 Lipocalin 2 18.146
PTGES Prostaglandin E 15.958
INHBA Inhibin beta-A 15.593
KRT19 Keratin 19 -26.767
ASPN Asporin -17.890
KRT8 Keratin 8 -14.161
IBSP Integrin-binding sialoprotein -12.914
COL1A2 Collagen, type I, alpha 2 -10.794
Lyz1/Lyz2 Lysozyme -8.718
H19 Imprinted maternally expressed transcript -8.222
COL1A1 Collagen, type I, alpha 1 -7.395
IGF1 Insulin-like growth factor 1 -6.578
CRYAB Crystallin, alpha B -6.199
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degrees of degeneration and found broad changes in
gene expression patterns, both with respect to the large
number of affected genes and the variety of known
functions [29]. In contrast to the present study, few of
the 47 genes identified by Gruber et al. to be differen-
tially expressed had known roles in disc degeneration.
In another study evaluating differences between disc
tissue harvested immediately post-mortem from patients
without known spinal pathology and tissue harvested
from patients with degenerative discs, Zhang et al. [30]
reported more than 500 differentially expressed genes.
Consistent with the results from our study, Zhang and
colleagues reported a significant upregulation of two
known regulators of disc degeneration: Mmp3 (3-fold)
Figure 3 Functional gene networks identified using Ingenuity Pathway Analysis (IPA) from differentially expressed genes between the
control and treated discs. (A) Network-1: cell death, cell cycle, and DNA replication, recombination, and repair (score 31). (B) Network-2:
cellular growth and proliferation, tissue development, and cancer (score 27). Node color indicates degree of overexpression (red) and the degree
of downregulation (green). Colored nodes represent genes of focus, whereas genes in uncolored nodes were not identified as being
differentially expressed and were consequently integrated into the networks based on information in the IPA database.
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and Il-6 (2.5-fold). Finally, Gruber et al. [31] recently
utilized microarray analysis and found more than 4,500
differentially expressed genes between early and
advanced stages of disc degeneration. Moreover, the
authors identified 23 with known roles in the homeosta-
sis of the ECM including collagen subunits, Aggrecan,
Adamts and metalloproteinase inhibitor 3 (Timp3).
Certain genes identified in our screen have previously
been studied for their role in the pathobiology of inter-
vertebral disc degeneration. Moreover, the similarity
with the previously identified expression patterns in
human disc degeneration suggests that our model accu-
rately recapitulates natural disc degeneration. IL-6 is an
inflammatory cytokine that has been associated with
Figure 4 Functional gene networks identified using Ingenuity Pathway Analysis (IPA) from differentially expressed genes between the
control and treated discs. (A) Network-3: cellular development, hematological system development and function, and hematopoiesis (score
27). (B) Network-4: carbohydrate metabolism and protein synthesis (score 16).
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disc herniation and discogenic pain in clinical studies
[35,36] but has been less well characterized with respect
to its cellular function compared to other inflammatory
mediators such as IL-1 or TNF-a. Studer et al. [37],
recently described contribution of IL-6 in the presence
of soluble IL-6 receptor (sIL-6R) in amplification of the
inflammatory response to IL-1 and TNF-a in NP cells.
The authors suggested that in the NP, IL-6/sIL-R path-
way may play a role in potentiating specific functions of
IL-1 and TNF-a such as downregulation of matrix pro-
duction and upregulation of prostaglandins and MMP3.
We found that both Mmp3 and Adamts5 were highly
upregulated in our model. MMP3 is an extracellular
zinc-dependent proteinase involved in digestion of non-
collagen matrix proteins and regulates ECM homeostasis
in healthy discs. Upregulation of Mmp3, however, is
associated with excessive degradation of the ECM, ulti-
mately depleting the hydrophilic nature of the NP and
the associated ability to distribute compressive load.
Similarly, the ADAMTS peptidases that degrade impor-
tant proteoglycans including aggrecan [10,38] are shown
to be upregulated in degenerative discs by both Le Mai-
tre et al. [39] and Pockert et al. [40]. SDC4 is a cell sur-
face proteoglycan that has been shown to be essential in
activation of the ADAMTS5 within the intervertebral
disc, thereby serving as an important regulator of ECM
homeostasis [10]. Our study found substantial upregula-
tion of Sdc4, confirming the important role Adamts play
in ECM regulation during disc degeneration. It is impor-
tant to comment that there is a strong correlation
between expression of senescent biomarkers and
increased gene expression of catabolic-degrading
enzymes in the disc. Thus up-regulation of many of the
catabolic enzymes in our model is likely a reflection of
senescent cell phenotype as indicated by our SA-b-gal
staining [26].
Disc degeneration also affects synthesis of ECM pro-
teins. Collagen I is an important structural protein
within the disc, particularly in the AF, which must resist
high tensile loads to maintain the disc shape and spine
alignment during axial loading. Disc degeneration is
typically associated with an upregulation of collagen I
that leads to a loss of compliance and hardening of the
NP. Interestingly, we found downregulation of two col-
lagen I alpha chains, contrary to what would be
expected. Although downregulation of collagen II and
upregulation of collagen I is eventually seen in a degen-
erative IVD, one explanation for these findings is that
Figure 5 Functional gene networks identified using Ingenuity Pathway Analysis (IPA) from differentially expressed genes between the
control and experimental discs. (A) Network-5: cellular movement, immune cell trafficking, and cell-to-cell signaling and interaction (score 24).
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the initial reparative attempts by the IVD normalize
ECM expression patterns, which only later become irre-
vocably altered.
Downregulation of asporin in the treated cells was
also contrary to expectations. Asporin was found to be
expressed at higher levels in human discs with more
advanced degeneration at both the protein and mRNA
level [41]. Furthermore, expression of a particular
asporin allele (D14) has been associated with the devel-
opment of disc degeneration in both Chinese and Japa-
nese populations [42]. Little, however, is known about
the molecular basis for these findings as the role of
asporin in the IVD has not been thoroughly character-
ized. Further understanding of the role of this molecule
in disc degeneration may provide greater insight into
potential explanations for downregulation of asporin in
organ culture models.
Other researchers have described organ culture models
to study disc degeneration, but used different processes
to induce degeneration. Roberts et al. [18], Chen et al.
[19] and Jim et al. [43] have all recently described sys-
tems that utilize injections of chemolytic enzymes to
degrade the ECM and induce a degenerative phenotype.
Although these models result in a phenotype consistent
with disc degeneration, the homology with the human
intervertebral disc degenerative process is questionable as
there is little evidence that the nonspecific global chemo-
lysis is the driving force behind human IVD degeneration
[29,30,43]. More work is needed to establish whether the
use of such enzymes is an appropriate way to induce
structural degeneration and inflammation for use in
modeling human disc degeneration. Similarly, many
organ culture models are based on needle puncture and
may be limited by this mechanism of disc injury. Annular
needle puncture in animal models and humans results in
clinically significant iatrogenic disc degeneration, how-
ever, it is unclear whether this model is an accurate
representation of disc degeneration commonly seen in
humans [44,45] that does not occur via this mechanism.
In contrast, induction of disc degeneration using IL-1b
and TNF-a mimics the pathways that drive inflammatory
processes and disease phenotype in humans.
Conclusions
Our results clearly demonstrate a widespread differential
regulation of genes largely consistent with previous
research into the molecular basis of disc degeneration.
Furthermore, results from our study found differential
expression in many genes known to be mediators of
inflammatory processes associated with disc degenera-
tion and regulators of extracellular matrix production.
Taken together, these findings suggest that the rat organ
culture model described can be used for further studies
designed to better understand the etiology of disc
degeneration and evaluate potential therapeutic
treatments.
Additional material
Additional file 1: Figure S1. Senescence-associated b-galactosidase
staining of rat nucleus pulposus (NP) cells following treatment with TNF-
a and IL-1b for 10 days. The result indicates that the number of SA-b-
gal-positive NP cells is increased in the experimental (B) versus the
control group (A).
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